Document is current
Any future updates will be listed below
-
Authors
Regev, Ravit https://orcid.org/0000-0002-0846-733X
Brener, Avivit https://orcid.org/0000-0002-2742-8264
Dror, Nitzan https://orcid.org/0000-0003-0813-7426
Krespi, Raphael
Rapalino, Rebeca
Chorna, Efrat
Borger, Ophir https://orcid.org/0000-0001-6019-4159
Lopez, Adar
Lebenthal, Yael https://orcid.org/0000-0001-5963-0574
Zeitlin, Leonid
- License Information
-
More Information
Article History
Received: 6 April 2025
Accepted: 15 December 2025
First Online: 8 January 2026
Declarations
:
: The studies involving human participants were reviewed and approved by Tel Aviv Sourasky Medical Center (TLV-0041-19). Written informed consent to participate in this study was provided by the participants’ legal guardian.
: Informed consent for publication was obtained from the parents of all three patients included in this study.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest. Authors RR, AB, YL, and LZ receive speaker fees, research funding, and travel grants from Medison Pharma. Authors RR and YL received advisory board compensation from Medison Pharma.
